Wilson Sonsini Goodrich & Rosati advised Verona Pharma on patent matters on the deal.Verona Pharma plc (Nasdaq: VRNA) announced that the U.S. Food and Drug Administration…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
